Scemblix (asciminib tablets) — Cigna

Initial criteria

• Patient age ≥ 18 years
• Patient has Philadelphia chromosome-positive acute lymphoblastic leukemia
• The medication will be used in combination with dasatinib

Approval duration

1 year